TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
FOXO Technologies ( (FOXO) ) has shared an update.
On September 9, 2025, FOXO Technologies Inc. entered into a Stock Purchase Agreement with Vector BioSource Inc. to acquire all of its equity securities. The acquisition involves a combination of cash, preferred stock, and warrants, with additional shares contingent on Vector’s revenue performance. This strategic move aims to enhance FOXO’s market position and operational capabilities, with the closing subject to due diligence and other conditions.
Spark’s Take on FOXO Stock
According to Spark, TipRanks’ AI Analyst, FOXO is a Underperform.
FOXO Technologies receives a low overall stock score primarily due to significant financial challenges, including continuous net losses, high debt, and negative cash flows. The technical analysis also suggests bearish momentum. Although valuation metrics are poor, recent corporate actions, such as acquisitions and restructuring, provide some hope for future improvement. However, these are not sufficient to outweigh the current financial and operational challenges facing the company.
To see Spark’s full report on FOXO stock, click here.
More about FOXO Technologies
Average Trading Volume: 7,710,747
Technical Sentiment Signal: Sell
Current Market Cap: $233.4K
Learn more about FOXO stock on TipRanks’ Stock Analysis page.